ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000814.1|K-252a_1 # 2 # 520 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.759	BGC0000814.1|K-252a_1 	2	520	-	Loose	650	25.409	tetA(58)	37.78	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGATGGCTCGTCACCGGCGGCGCCGGGATGCTGGCCCGCGACGTGCTCGGCCGGGCCGCGCTGATCGGCGACCCGGTGCTGGCGCCCGGCCGGGCCGAACTCGACCTGTGCGACGGCCGCGCGGTGCGTGAGCTGGTGGGCTCCTACCGGCCCCGGGTCGTCGTCAACTGCGCGGCCTGGACCGCCGTGGACGACGCCGAGGCCCACGAGGCCGAGGCGCTGGCCGTCAACGGCCACGCGGTGCGGGTGCTGGCCGAGGCGTGCGCGCGTTCGGGCGCCCGGCTGCTGCACCTGTCCACGGACTACGTGTTCGACGGGGCGAGCGCGGCGCCGTACCGGGAGGACGCGCCGACGGGGCCGGTCAACGCCTACGGCAGGACCAAGCTGGCCGGGGAGGCGGCGGCGCTGGAGCACGGCCAGTACGTGGTGCGCAGCGCCTGGTTGTACGGGGCCGGTGGCGCCAACTTCGCCCGCACGATGATCAGGCTCGCCGGGCAGGTCCAGACCGTGGACGTG	MRWLVTGGAGMLARDVLGRAALIGDPVLAPGRAELDLCDGRAVRELVGSYRPRVVVNCAAWTAVDDAEAHEAEALAVNGHAVRVLAEACARSGARLLHLSTDYVFDGASAAPYREDAPTGPVNAYGRTKLAGEAAALEHGQYVVRSAWLYGAGGANFARTMIRLAGQVQTVDV	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	50.44	gnl|BL_ORD_ID|2243|hsp_num:0	2517			51	186	tetracycline
BGC0000814.1|K-252a_2 # 517 # 1446 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.718	BGC0000814.1|K-252a_2 	517	1446	-	Loose	1200	48.521	arnA	24.27	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAGAAGATCCTGGTGACCGGCGGGGCCGGGTTCATCGGCTCGCACTTCGCGCGCGGGCTGGGCGGCGCCGAGGTGACCGTGCTCGACAAGCTCACCTACGCCGGCAACCGGGCCAACCTGGACGGGGTGCCGCACGCGTTCGTCCACGGCGACATCTGCGACGCCGGGCTGCTGCGCGAGGTGCTGCCCGGCCACGACCTGGTGGTCAACTTCGCCGCCGAGTCCCATGTGGACCGTTTGATCGAGGGGGCGGCCGAGTTCGTGCGCACGAACGTGCTGGGCACCCAGACCCTGCTGCAGGGCTGCCTGGAGGCGGGCGTGCGCAAGGTCGTCCAGGTCTCCACCGACGAGGTGTACGGCTCGATCGGCGTCGGCTCGTGGACGGAGTCGGCGCCGCTTCGGCCGCGCTCGCCGTACGCGGCGGCGAAGGCGGGCGGCGACCTGGTCGCCCAGGCCTACGCGATCACCCACGGCCTCGACGTGTCGATCACCCGGTGCGGCAACAACTACGGGCCCCGGCAGTACCCGGAGAAGATCATCCCGTTGTTCGTCACGAGACTGCTGCGCGGCGAGCGGGTGCCGCTCTACGGCGACGGCGGCAACGTGCGCGACTGGGTGCACGTCGCCGACCACTGCGCGGGCATCCGCCTGGTGGCGGAGGTCGGCCTGCCCGGCGAGGTGTACCACATCGCGGGCACCGCGGAGATGACCAACAAGGAGCTGGTCGGGCACCTGCTGGCGGCGTCCGACGCGGACTGGGGGCGGGTCGAGTACGTCGAGGACCGCAAGGGCCACGACCGCCGCTACTCGCTCGACGACCGCCGACTCAGGGCGCTGGGCTACCGCCCCGAGGTCGAGTTCGACCAGGGGCTGCGCGACACCGTGCGCTGGTACGCCGCCAACCCCGGCTGGTGGGCCGGGTCATGA	MKKILVTGGAGFIGSHFARGLGGAEVTVLDKLTYAGNRANLDGVPHAFVHGDICDAGLLREVLPGHDLVVNFAAESHVDRLIEGAAEFVRTNVLGTQTLLQGCLEAGVRKVVQVSTDEVYGSIGVGSWTESAPLRPRSPYAAAKAGGDLVAQAYAITHGLDVSITRCGNNYGPRQYPEKIIPLFVTRLLRGERVPLYGDGGNVRDWVHVADHCAGIRLVAEVGLPGEVYHIAGTAEMTNKELVGHLLAASDADWGRVEYVEDRKGHDRRYSLDDRRLRALGYRPEVEFDQGLRDTVRWYAANPGWWAGS	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	46.68	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1950	polymyxin B
BGC0000814.1|K-252a_4 # 2512 # 3411 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728	BGC0000814.1|K-252a_4 	2512	3411	-	Loose	500	40.817	rmtC	27.4	3000861	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGGTGAACATCCCTTTCCAGCGAAACCAGAAGGAGTCTTCGATGGTCAACACCTCAGCCAAGGGCGCGTTCGACGGTGTCTTCGACAAGGTCGCCGGCGAGTACGACACCGAGGGCGTGCTGTTCTTCAGGCCCGTCGCCGAACGGCTCGTCGAACTGCTCGGCATCGAGAAGGGACAGCAGATCCTCGACGTCGGCTGCGGCCGGGGCGCGGTGACGTTCCCCCTCGCCGAGGCCGTGGGCCCGACGGGCCGGGTGTTCGGCATCGACCTCTCGGCGGGCATGGTCGAGGCGCTGCGGGCGTCGGTCGCGGCGGCGGGCGTGCCCAACATCGAGGTCCGGCACATGGACGGCCAGCGCCCCGGATTCGAGCCCCGGGAGTTCGACGCGATCACCGGCAGCATGAGCATCGTCATGCTGCCGGACCTCGCCGCCGCCTTCCGTGACTACGCGCGCCTGCTCCGGCCCGGCGGCACGCTGGCCTTCACCGCGCCGGACACCCGCAACCAGATCGGCGCGTGGAAGACCGGCCCGGTCGACATCGGCAGGCTCGCCGCCGAGATCCCCGGCGAGGCGCTGCGCGCGCACCCGATGCTGGCCAGGCTGATCAACGGCGATCTGCTCGACCTGTCGGCCGTGCCCGCGCTGCTGGCCGAGGCCGGGTTCGCCGACGTCGTGGAGCACCGCGAGGAGATCGCGGTCGTCGCCGACACCCCGGCCGGGCTGGTGCGCTGGACGCAGCAGCACGGCATGCGCGCGGTGTGGGACGCGGTCCCCGACGGCCGCCGGGCGGCGGTCGAGCGGGCGCTGACCGCCGACGCGACGGCGCAGGCGGGCGCCGACGGCAAGGTCCGCTTCGGCTTCCCCGTCGCCTACTTCGTGGCCCGAGGCGGGGCGTGA	MVNIPFQRNQKESSMVNTSAKGAFDGVFDKVAGEYDTEGVLFFRPVAERLVELLGIEKGQQILDVGCGRGAVTFPLAEAVGPTGRVFGIDLSAGMVEALRASVAAAGVPNIEVRHMDGQRPGFEPREFDAITGSMSIVMLPDLAAAFRDYARLLRPGGTLAFTAPDTRNQIGAWKTGPVDIGRLAAEIPGEALRAHPMLARLINGDLLDLSAVPALLAEAGFADVVEHREEIAVVADTPAGLVRWTQQHGMRAVWDAVPDGRRAAVERALTADATAQAGADGKVRFGFPVAYFVARGGA	MKTNDNYIEEVTAKVLTSGKYSTLYPPTVRRVTERLFDRYPPKQLEKEVRKKLHQAYGAYIGGIDGKRLEKKIEKIIHEIPNPTTDEATRTEWEKEICLKILNLHTSTNERTVAYDELYQKIFEVTGVPTSITDAGCALNPFSFPFFTEAGMLGQYIGFDLDKGMIEAIEHSLRTLNAPEGIVVKQGDILSDPSGESDLLLMFKLYTLLDRQEEASGLKILQEWKYKNAVISFPIKTISGRDVGMEENYTVKFENDLVGSDLRIMQKLKLGNEMYFIVSRL	106.41	gnl|BL_ORD_ID|1417|hsp_num:0	1540			324	537	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0000814.1|K-252a_7 # 5745 # 6974 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.733	BGC0000814.1|K-252a_7 	5745	6974	-	Loose	550	28.4906	Nocardia farcinica rox	31.03	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGAGATCCGAAGAGCTGCTGGACGCGCCGCACGTGGACGTGCCGACCATTCCGGCGCCCGTGGACGTCCTGCCGAGCCTGGTCGCGGCGGGCCGCGTCGCGCCGGTCGTCAAGGTCGACTACTACGGGGGCACCGCGTGGGCGGTCACCGACATGGAACTGGCGCGCGCCGCCTTCACCGACCGCAGGCTCAGCAAGGACATCGAGCTCACCCCCGAGTGGATGCGGCGGGTGACCGGTGTCATGATCGGCTCGCAGCCGCGCGCCGACGTCGCCCGCACGATGGTGATGAGCGAGGGCCCCGAGCACGCCCGCATCCGGCGCCTGCACGCGCGTGTCTTCACACCGCGCAACACCGAGAGGTGGGGCGCCCGGCTGGCCGCGCTCGCGGAGGAACTGCTGGACGGGCTGTCGGGCGAGCTGAACCTCATGGAGCGCTACGCCTACCCGCTGCCGCTGGCCTTCATCGGCGAGATGCTCGGCCTGCGGCCCGAGATGTACGCGGTGATGCGGCGGGCCACCGACGCCATCATCTACTCGCCGAAGCAGGAGGAGCGAGCGGGCGGCGTCGGCGCGCTGGCCGGCGCGGTGGCGGGCTGGGCCGCCGACCCGGGCCCCCTGGCCGAGGGGCTGATCACCGGCCTGCTCGACGCCGTGGACGGCGAGGAGGCCATCACCCCCGACGAGGTCGTGACCTGGACGGTCGGCCTGGTGATGGCGGGCTACGAGTCCACGGCGAGCCTCATCTCCGCCGGGATCCTGGAGGCGCTCGGCCGCGACGCCGGCGCCCGGCCGCGCACCCCCGAGCAGATCGACGGGTGGATCGAGGAGACGCTGCGCGTGCACCCGCCGTTCCCGCACGCCACCTGGCGGTTCGCCACCGAGGACGTGAACCTCGGCGGCTACCTGATCCCCGCGGGGGCGCCCGTGCAGATCAACGTGGCGGCGGCCAACCGCTGCCCGCACCACGAGCGCACCGGCGAGTTCGACCCCGAGGCGGGCCGGGGCCACATCAGCTTCGGACTCGGCCACCACTACTGCCTCGGGGCGCCGCTGGCCCGTCTGGAGGCCCGGATCGCGCTCACCGCGTTCTTCCGCCGTTTCCCGCACGCCAGGCTCAGCGAGCGGACCGAGGTCGGATGGGAGTCCGAGTGGATGACCCGCCGCATCAGCGTCCTGCCCGTCGTGCTGGCAGGCCCCACCCCGAATCCGGAAGGGATGACCCCGTGA	MRSEELLDAPHVDVPTIPAPVDVLPSLVAAGRVAPVVKVDYYGGTAWAVTDMELARAAFTDRRLSKDIELTPEWMRRVTGVMIGSQPRADVARTMVMSEGPEHARIRRLHARVFTPRNTERWGARLAALAEELLDGLSGELNLMERYAYPLPLAFIGEMLGLRPEMYAVMRRATDAIIYSPKQEERAGGVGALAGAVAGWAADPGPLAEGLITGLLDAVDGEEAITPDEVVTWTVGLVMAGYESTASLISAGILEALGRDAGARPRTPEQIDGWIEETLRVHPPFPHATWRFATEDVNLGGYLIPAGAPVQINVAAANRCPHHERTGEFDPEAGRGHISFGLGHHYCLGAPLARLEARIALTAFFRRFPHARLSERTEVGWESEWMTRRISVLPVVLAGPTPNPEGMTP	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	86.47	gnl|BL_ORD_ID|4834|hsp_num:0	5821			33	207	rifampin
BGC0000814.1|K-252a_8 # 6971 # 8281 # -1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.759	BGC0000814.1|K-252a_8 	6971	8281	-	Loose	700	79.7221	oleD	24.83	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	TTGGCACACGTTCTGATCGCGACGACCCCGGCTGACGGCCACGTCAACCCGGTGGTCCCGGTCGCGCGGAACCTGGTGCGCGCCGGCCACGACGTGCGCTGGTACACCGGAGACGGCTACCGGAGCAAGATCACCGCCGTCGGCGCGCGGCATCTGCCGATGTTCGCGGCGCACGACTTCTCCGGGCAGAGCAAGGCCGAGGCGTTCCCCGCCCAGGCCCGGCTCACCGGCGCGGCGAGTTTCGTCGCGGGGATGCGGGACATCTTCTACCGCACCGCGCCGGACCAGATGGACGACCTGCTCCGGGTGCTGGACCGGTTCCCCGCGGACGTGCTGGTGTCCGACGACATGTGCTACGGCGCGAGCTTCGCCGCCGAGCACACCGGGCTGCCGCACGTGTGGATCGGCAACTCGATCTACGTGCTGGGCAGCCGCGACACCGCTCCGCTCGGGCGCGGCCTCGGCCCCTCGGCGACGCGGGCGGGCCGGTTGCGCAACGCCGTGCTCGCCTGGGCGGGCGATCACATCATGCTGCGCGGGCTGCGGCGGGCGGCCGACGCGGCCCGCGCGCAGGCGGGGCTGGCCCGCCTGCGCGCGGGCGGGATGGAGAACATCGCCCGCCGTCCCGACCGCTATCTTGTGGGCACCGTCGCCGAGCTGGAGTTCCCGCGCTCCGACCTGTTCGCGGGCACGCACTTCGTCGGCGCGCTCGACCTGCCGCCGTCGGACACGGCCTTCGACCCGCCGCCGTGGTGGGAGGAGCTGCGCGGCGAGCGGCCGGTCGTGCTGGTCACCCAGGGCACGATCGCCGACGACGCGCGCCGGCTGCTCCTGCCCGCGATCCGGGCGCTCGCCGACGAACCGGTGCTGGTCGTCGTGACCACCGGCAACCGCACGCTCGGCCCGAGCGCCGGGACGCTGCCCGCGAACGTGCGGGTGGAGGGCTTCGTGCCGTACCACCGGCTGCTGCCGTACGTGGACGTCATGGTCACCAACGGCGGCTTCAACGGCGTCACGGCGGCGCTCAGGCACGGCGTCCCGCTGGTCGTCGCCGGGGCCACGGAGGAGAAGGCGGACGTGGCCGCCCGGGTGGCGTACGCGGGTGCCGGGGTGGCGCTGCGGGGGGCGCGGCTCGCCCCGGAGCGGGTGCGCGCCGCCGTACGGGCGGTGCTGGACGGCCCGGAGCACCGGGCCGCCGCGGCCCGGCTGCACGACGCCTTCGCCCGGCACGACGGCCCGCGCCGGGCCGCCGAGCTGATCGAGGAACTGATCCCCGCCCGCACCGCGCCCGCCACCGGAGGCCCGCTGTGA	MAHVLIATTPADGHVNPVVPVARNLVRAGHDVRWYTGDGYRSKITAVGARHLPMFAAHDFSGQSKAEAFPAQARLTGAASFVAGMRDIFYRTAPDQMDDLLRVLDRFPADVLVSDDMCYGASFAAEHTGLPHVWIGNSIYVLGSRDTAPLGRGLGPSATRAGRLRNAVLAWAGDHIMLRGLRRAADAARAQAGLARLRAGGMENIARRPDRYLVGTVAELEFPRSDLFAGTHFVGALDLPPSDTAFDPPPWWEELRGERPVVLVTQGTIADDARRLLLPAIRALADEPVLVVVTTGNRTLGPSAGTLPANVRVEGFVPYHRLLPYVDVMVTNGGFNGVTAALRHGVPLVVAGATEEKADVAARVAYAGAGVALRGARLAPERVRAAVRAVLDGPEHRAAAARLHDAFARHDGPRRAAELIEELIPARTAPATGGPL	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	105.06	gnl|BL_ORD_ID|1253|hsp_num:0	1367			21	1203	erythromycin; tylosin
BGC0000814.1|K-252a_9 # 8469 # 10004 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGGGA;rbs_spacer=14bp;gc_cont=0.725	BGC0000814.1|K-252a_9 	8469	10004	+	Loose	800	38.891	tet(48)	32.14	3004581	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGGGTCCGCCCCGGCCCGCCGACGATGGGGCTCACCTGCGGTTCGACACACCGTCGAAAGGGAGGAACACCCCTATGTTCAGTCGTCTACCGAATGTGCGGGAGCCCCGGCGGGTCACCGTACTGGGCGCGGGCGTGGCGGGGCTGGTCGCCGCCTACGAGCTGGAACGGCTCGGGCATCAGGTGGAGATCATCGAGGCGGCCGACCGGGTCGGCGGCCGTGTTCACACGCACCGGTTCGGTTCGGCCCCCGGCGCCCCGTTCGCCGACCTGGGCGCGATGCGGCTGCGCACCGACCACACGCGTACCCTGCACTACGTCGTCGAGCTGGGCCTGCACAACGACATCCGCGAGTTCCGCACGCTGTTCGCCGACGACGGCAACCTGCTGTCGATCCACGACGAGCGGCACATCAGGGTGCGCGAGGCCCCGGACGTGCTCACCGGCAGGCTCGCGGCACGGCTCGGCGACCACTCCTACCGGCCGGCCACGCTGCTGTTCGGGGCGTGGCTGCACGCGTGCCTGGAGGCCATCGCGCCCCGGGACTTCAACGACTGGCCGGAGGTCACCACCGAACTGCTCGATCTGGTCGACGGCATCGACCTGGAGCCGTACCTGCACCCCGCCGGGTCCAAACCGGACCTGTACGCCGTGGTGAAGGACCACCCGCAGATCCGCTCAGGACCCTTCAGAGGCCGCGAGCGGCTGCTGGACGACGTCCTGGACGAGACCAGCCCCGCGCTCTACCGGCTGCGCGGCGGCATGGAGACGCTCACGAACGCGCTGGCCGCGCGCATCCAGGGCCCCATCTGGCTGAACCAGGAGGTGACCGGGATCGCGGTGCACGACGACGGCGTGGCGGTCGGCGTCCGGCGCGGCGGCCGGATCCGCTACCGGAACTACGACCACGTACTGTGCACCATCCCGTTCACCGTGCTGCGCGGCCTGCGGCTCGACGGGTTCGACGCGGACAAGCTCGCCGCCGTCCACGAGACCCAGTACTGGCCGGCGACCAAGATCGCGCTGCGCTGCCGCGAGCCGTTCTGGGCCGCCGACGGCATCGCCGGCGGCGCCTCGTTCACCGGCGGGCTGGTCCGCCAGACCTACTACCCGCCCGTCGAGGGCGACCCGGCGCAGGGCGCGGTGCTGATCGCCAGCTACACCATCGGCCCGGACGCCGAGGCGCTGGGCAGGCTCGACCCGGCCGCCCGCCGACAGGTGGTCCTGGACGAGGTCGCCCGGATGCACCCCGGCCTGCGGGAGCGCGGCATGATCCTCGACACCGCCGGCCGCGCGTGGGGCGAACACCGGTGGAGCCTGGGCGCGGCCACCATCCGCTGGGGCCAGGACGCCGGCACCCGCAAGGAGCAGCAGTGGGCGGCGGCCCGGCCGCAGGGCAGGCTGTTCTTCGCGGGCGAGCACTGCTCGTCCATGCCGGCCTGGATCGAGGGCGCGATCGAGTCGGTCACCGACGCGCTGCGCGACATGGAGACCCGCGACCCGCACGAACTGATGCGGCTGGATCTGGGCCGATGA	MGPPRPADDGAHLRFDTPSKGRNTPMFSRLPNVREPRRVTVLGAGVAGLVAAYELERLGHQVEIIEAADRVGGRVHTHRFGSAPGAPFADLGAMRLRTDHTRTLHYVVELGLHNDIREFRTLFADDGNLLSIHDERHIRVREAPDVLTGRLAARLGDHSYRPATLLFGAWLHACLEAIAPRDFNDWPEVTTELLDLVDGIDLEPYLHPAGSKPDLYAVVKDHPQIRSGPFRGRERLLDDVLDETSPALYRLRGGMETLTNALAARIQGPIWLNQEVTGIAVHDDGVAVGVRRGGRIRYRNYDHVLCTIPFTVLRGLRLDGFDADKLAAVHETQYWPATKIALRCREPFWAADGIAGGASFTGGLVRQTYYPPVEGDPAQGAVLIASYTIGPDAEALGRLDPAARRQVVLDEVARMHPGLRERGMILDTAGRAWGEHRWSLGAATIRWGQDAGTRKEQQWAAARPQGRLFFAGEHCSSMPAWIEGAIESVTDALRDMETRDPHELMRLDLGR	MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK	128.07	gnl|BL_ORD_ID|2720|hsp_num:0	3284			3	252	tetracycline; oxytetracycline
BGC0000814.1|K-252a_11 # 13093 # 14670 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=10bp;gc_cont=0.747	BGC0000814.1|K-252a_11 	13093	14670	+	Loose	600	122.865	Streptomyces venezuelae rox	29.14	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACTCGCAGCGAAGAGACCGACGTCCTCATCGTGGGCGGCGGCCCCGTGGGCCTGGCCCTGTCACTGGACCTCACCCATCGCGGCGTCCGGCACATCGTGATCGACGCGGGCGACGGCGTGGTGCGCCACCCGAAGGTCAGCACGGTCGGGCCGCGCTCGATGGAGCACTTCCGCCGCTGGGGGGTGGCCGGGCGGGTCAGGGACGCGGGCTGGCCGCCCGGTCACCCGCTCGACATCGCGTGGGTGACCCGCGTCGGCGAGTACGAGATCCACCGGTTCGAGCGCGGCACCGCCGCCGCCCGCCCGGTGTTCCGCCACACGCCGGAGCCGGACCAGGTGTGCCCGGCCCACCTGCTGAACCCGGTGCTGGCGGGCGCGGTGGGCAGGCCGCTGCGCTACCTGCACCGCCTGGAGCACTTCGAGCAGGACGCCGGTTGCGTGCGGGCCACGATCTCCTCGAACGGCGAGGAATCGGTCGTCTGGGCGCGCTATCTGGTGGCCTGCGACGGCAGCTCCTCCGTCGTGCGCAAGGCCCTCGGCATCGACTCGCCCGCCCGCCACGAGGCGCAGGTCTTCCGCAACGTGCTCTTCCGCGCGCCGGGGCTGCCCGCGCGCCTCGCGGAGCGCGGCCACCGGAGCGCGCTGGTGTACTACCTGATGCACTCCTGGTCGCTGCGCTACCCGATGCGTTCCCTGGACGGGCGCGGCCTCTACAACATGGTCGTGGACGGCCGCTCCGACCAGGGCGCGCTGGAGCTGATCCGCTCCGCCATCGCCTTCGACGTGCCGGTCGAGCTGGTCGCCGACGGCCTGTGGCACCTGACCCACCGGGTGGCCGACCGGTACCGGGCGGGCCGGGTGTTCCTGGCGGGCGACGCGGCGCACACGCTGTCGCCGTCCGGCGGGTTCGGCATGAACACCGGCATCGGCGACGCCGCCGACCTGGGCTGGAAGCTCGCCGCCGCCGTCGCGGGCTGGGCGGGCGACGGCCTGCTCGGCACCTACGAGACCGAACGCCGCCCGGTGGCGATCGCCGGCCTCGACGCGGCCGAGGCGAACCTGCGGCGTACGGTCGACCGCGACCTCCCCGCCGAGCTGGCCGCGTCCACGGAGAAGGGCGCGCGGCTGCGGGCGGAGATGGCCGAGCGGCTGGTGAACAGCGGCGCGCGCGAGGAGTTCGACGCCCCCCGCGTCCATTTCGGGTTCCACTACCGCTCGCCGATCGTGGTCTCCGACGGGCCGGCCGAGCAGGGCCCGAGGTGGCGGCCGGGCAGCGACCCGGGCTGCCGCGCCGCCCACGCGTGGGTACGCCCGGGGGTGTCCACGCTGGACCTGTTCGGGGACGGCTTCACGCTGCTGCGCTTCGCCGATTCGCCCGCACTGTCCGCGTTCGTTACGGCCTTCACCGAGCGCGGCGTGCCGTTCCGGTCGGTGCTCGTGGGCGACCCGGACACCGCCGCCCTGTACGGTCACCGTTTCGTCCTGGTCCGCCCCGACGGGCACGTGGCCTGGCGCGGAGACGACCTGGAGGCGGCTCCCGCGAACCTGGCGGATCTCGTGCGAGGGGCGGGGTGA	MTRSEETDVLIVGGGPVGLALSLDLTHRGVRHIVIDAGDGVVRHPKVSTVGPRSMEHFRRWGVAGRVRDAGWPPGHPLDIAWVTRVGEYEIHRFERGTAAARPVFRHTPEPDQVCPAHLLNPVLAGAVGRPLRYLHRLEHFEQDAGCVRATISSNGEESVVWARYLVACDGSSSVVRKALGIDSPARHEAQVFRNVLFRAPGLPARLAERGHRSALVYYLMHSWSLRYPMRSLDGRGLYNMVVDGRSDQGALELIRSAIAFDVPVELVADGLWHLTHRVADRYRAGRVFLAGDAAHTLSPSGGFGMNTGIGDAADLGWKLAAAVAGWAGDGLLGTYETERRPVAIAGLDAAEANLRRTVDRDLPAELAASTEKGARLRAEMAERLVNSGAREEFDAPRVHFGFHYRSPIVVSDGPAEQGPRWRPGSDPGCRAAHAWVRPGVSTLDLFGDGFTLLRFADSPALSAFVTAFTERGVPFRSVLVGDPDTAALYGHRFVLVRPDGHVAWRGDDLEAAPANLADLVRGAG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	110.29	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1380	rifampin; rifaximin; rifapentine
BGC0000814.1|K-252a_13 # 15853 # 18825 # -1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.753	BGC0000814.1|K-252a_13 	15853	18825	-	Loose	390	36.965	evgA	32.14	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGTAACCGGGCGTTCACCGACCACCGGTAGACAAGGAAGAGCTGGGGCCTCGTCCCGCGACAGCGCGGCGAGGGCGACACAGGTGGTCGACCTGATGACGGCCATCGTCGCGGCCGACGAGATCGACGCCGCACTGCGGCGCAGCGACTACGAGGCAGTGATGGGAAAGGGGCTGGCCCGCATGGTCGAGGTACGGCATCTCCGTACGAATGCCGCGTCGTCCGCAGTACCGCGCGCCCTGCACCCGCGACGGGTCGCGGTGCGGACCCGGCGCGCGGTGCGAGGGCGGCAACAGGAGCGGCAGCGGCTCGCCGCCGTGCTCGACGTGACAGCCGCCACAGGACGCGGCGCGGTCGTCGCGGTGACCGGAAGAGCGGGTATCGGCAAGACCACCGTCCTGTCCGAACTCCGGGCCGTCGCGGCGGACAAAGGGTTCACCGTCGTCGGCGTCGGCTCCGACGAGGACCTGCGGCCGGAGGCGTTCGCCGCGCTCCTCGTGGGCGGCCGGCCGGCCGTCGCGGGCTGCGAGGGCGCGTTCGGCGCCATGCTCGACGGGCATCTCGCGCGCGGCCCCGTGCTGGTCACCGTGGACGGCCTGCAGTGGTGCCACGCGGTGGCCGCCCGCACGCTCGACGCGCTGGCGGCCCAGGCCGCGCTCCGGCCGCTGGTGTGCGTGGTCGCCGAGCGGCCCGAGATGGACCGGCCGTACCTGGACCAGTGGCGCGGCCACCTGCGCCAGCGGCCGGACGCGGTGCGGGTGGAACTGCCCAGGATGGCGGGTCCGGAGGTCGCGGCGCTCGTGGAGGACGTGCTGGGCGTCCCGCCGGACGCCAGCCTCACCATGCTCGTCGACTGCGCGGGCGGCATCCCGGCGACGGTCGTGGAACTGCTCGGCGTCGTGGCGGACGAGGGCGTGAAGGAGTGCCAGGCGGACTTCGCGCGGATCACCCGGCTCCTGGGCGGCGAACGCCACGAACCGCTCCTGAACGGCGGCGCGGCGCTGCCCCACCGATTCAGCCAGGTGCTGCACCGCAGCCTGGACTGTCTGTCGGAGGAGACGCGGCGGGTGCTCGACGTGGCCTCGGTGCTCGGCCGCACGTTCCTGCCCGACGACCTGGCGACGCTGCTCGGCCAGCCGTTGGCCGCGCTGCTGCCCGCCTTCCGCGAGGCGTTCACGTCCGAGGTGCTGGAGAGCGCCGAGCAGAGCATGCGCTTTCGCAACACGCTGCTGTGGCAGGCGCTGCTGCAGAACATCCCGGACGCCGTCCGGGGAGCGCTGCACCGCCAGGCGGCCGCGATGATCATCGCGCGGGGCGGTTCACGCGTCGACTCCGCCTGCCACGTGGCGCGGGGCGCGTTCCACGGCGACGAGGCCGCGATCCTGCTGCTGCGCGACGCGGCGGAGGAGGCACTGCGGCCCGCGCCGCGCACCGCCGCCGAGCTGGCGCTGCGCGGGCTGGAGCTGCTGCCCCCGGGTCACGCGGCCTGCCTGCCGCTGACCGAGATCGCGGTCGAGGCGTGCGCCCGCTCCGGCCCGATCTCGCGAGCCGTGAGGCTCGCCGAGGACGCGCTGACCGGCCCGCTCCCCGAGACCGCCAAAACCGCGCTGCGGTACTGGCTGTCCACCGCGCTGACCCTGGAGGGCAGGCACCGCGACGCCGGGCGCGTCGCCGAGTCCGTGCTGTCCAACCCGGCGGCGCCCGCGGAGCTGCGCCACAACCTCACCGTGAACCAGGTGCTGGTCAGCGTCCTGCGCCGCGACCAGCCGCCGCCCGAGCGCCGGGGCGTCGGCGAGAGCGACTTCCCGGTGCTGGCGGCCATGCGGAGCTGGCGCGAGGGCAGGCTCACCGAGGCGCTCACGCTGTGCCGCAAGGCCGTGGCCGACGACCACGGCGGGCCGGTCATCAGCTGGATCTGCCATCCGCTGATCGGCCTGGCCGAGGTGCTGACCTGCCTGGAGCACCACGACGAGGCGCTGGCCGTGATCGACGAGACGGCCGAGCACGTCGACCGGGCGCTGGCCGCCGTGCCACACATCCTGCGCGCCCGCGTGGAGCTCGCGGTCGGCCGTACCTCGAACGCCACGGCGGAGGCGCTGGCGGGCCTGCGCATCGCGCACGACACCGGCACCCACCTGTACCTGCACGAGGCCCTGTACGTTCTCACGACCGCGACCCTGCGCACCGGCGTGGGCCGCCCGCGCGGGGAGGACCCGCTGGTCGCCTGGGCTCGCGCCGAGACGTCGGCGGTGCGCTCGCTGCCGCTGGCCTGGGCGGAGGCCCGCCTGGCCGAGGCGCACGGCGACCCGGCCCCTGCCCGCGCCCTGCTGCGCGAGGTGGCGCTGGGCGAGCAGCAGCGCCGCGAGCTGTTCGCCAGCGCGGCCGGCGCGGCCGCGTGGACGGTGCGCACCGCGCTCGCCGAGGACCGAGGCGACTGGGCCGCCGCCGCCGTGACGACCGCCGAACGACTGGCCGCGGCCAACCCGGAGGTCCGCACCATGGCCGCCGCCGCCGCGCACGCACGCGGCCTGCTGGAGCGTGACAGCGCGGCACTGGCCGCCGCCTCGGCCTTCCCCGGCCCGTGGGAGCGCGCCTCGGCGGCCGAGGACCTCGGCCGGGTGCTCCTCGACGCCGACCGCGAGTCGGCCGTACGGCATCTGGAGCAGAGCGCGGCCCTCTACCAGGAGATCCTCGCCGACCCGGACGCCACCAGGGTCCGGAGCGTGCTGCGCGCGGCGGGCGTGGTGCGCAGGCACTGGAGGCAGCGCGGTTCCGGCGAGAGCGCCGACACACTCACCGACACCGAGCGCAAGGTCGCCGACCTGGTCGCCTCCGGACTGACGAACCAGCAGGTGGCGCGGCGGATGTTCATCTCGCACCACACGGTCGCCTTCCATCTGCGGAAGGTGTTCCGCAAGCTGGAGGTCACCTCGCGGGTGGAGCTGGCGCGCCGCTTCCAGCCGTCCCGATAG	MVTGRSPTTGRQGRAGASSRDSAARATQVVDLMTAIVAADEIDAALRRSDYEAVMGKGLARMVEVRHLRTNAASSAVPRALHPRRVAVRTRRAVRGRQQERQRLAAVLDVTAATGRGAVVAVTGRAGIGKTTVLSELRAVAADKGFTVVGVGSDEDLRPEAFAALLVGGRPAVAGCEGAFGAMLDGHLARGPVLVTVDGLQWCHAVAARTLDALAAQAALRPLVCVVAERPEMDRPYLDQWRGHLRQRPDAVRVELPRMAGPEVAALVEDVLGVPPDASLTMLVDCAGGIPATVVELLGVVADEGVKECQADFARITRLLGGERHEPLLNGGAALPHRFSQVLHRSLDCLSEETRRVLDVASVLGRTFLPDDLATLLGQPLAALLPAFREAFTSEVLESAEQSMRFRNTLLWQALLQNIPDAVRGALHRQAAAMIIARGGSRVDSACHVARGAFHGDEAAILLLRDAAEEALRPAPRTAAELALRGLELLPPGHAACLPLTEIAVEACARSGPISRAVRLAEDALTGPLPETAKTALRYWLSTALTLEGRHRDAGRVAESVLSNPAAPAELRHNLTVNQVLVSVLRRDQPPPERRGVGESDFPVLAAMRSWREGRLTEALTLCRKAVADDHGGPVISWICHPLIGLAEVLTCLEHHDEALAVIDETAEHVDRALAAVPHILRARVELAVGRTSNATAEALAGLRIAHDTGTHLYLHEALYVLTTATLRTGVGRPRGEDPLVAWARAETSAVRSLPLAWAEARLAEAHGDPAPARALLREVALGEQQRRELFASAAGAAAWTVRTALAEDRGDWAAAAVTTAERLAAANPEVRTMAAAAAHARGLLERDSAALAAASAFPGPWERASAAEDLGRVLLDADRESAVRHLEQSAALYQEILADPDATRVRSVLRAAGVVRRHWRQRGSGESADTLTDTERKVADLVASGLTNQQVARRMFISHHTVAFHLRKVFRKLEVTSRVELARRFQPSR	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	485.29	gnl|BL_ORD_ID|936|hsp_num:0	1015			414	582	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000814.1|K-252a_14 # 18989 # 19087 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.646	BGC0000814.1|K-252a_14 	18989	19087	-	Loose	550	20.0162	OXA-931	43.33	3005330	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACCCCATATCCCGGCTGGCCGCCAAATGGCCTTTACCACTGGCCGGTAGTGGAACTGGGCGCTGTCGGCAATGCCGGGAACGACCCGGCTCCCTAG	MTPYPGWPPNGLYHWPVVELGAVGNAGNDPAP	MKFKMKGLFCIILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHLKSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAEAMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFAYQLAMKQLPFDSNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKVTAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR	11.59	gnl|BL_ORD_ID|3035|hsp_num:0	4062			684	768	cloxacillin; oxacillin; cefalotin
BGC0000814.1|K-252a_15 # 19084 # 21261 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGAGG;rbs_spacer=9bp;gc_cont=0.742	BGC0000814.1|K-252a_15 	19084	21261	-	Loose	650	76.6406	Enterococcus faecium liaS mutant conferring daptomycin resistance	28.14	3003079	protein variant model	E192G	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	daptomycin resistant liaS	GTGAGGTTCGTCGGGCGGTGGCGTGGGGCCCTGCTGGAAACGGAGACCCAGACGACTGCCTGGACAAGTGATCGGATCGCCGACGAGCAGGGGGCGCTGCGGCGGGTCGCGACGCTGGTCGCCCAAGGGGCGGCGACCGACGAGGTGTTCACCACCACCACCGCGGAGGCCGGGCGGCTGCTCGGAGTGGATCTCGCGGTTCTGAACCGGTACGAGGCGGACGGCACCATGACCGTGCTGGGCGCCTGGAGCGGCCCGGACGGCCTCACCCCCGTTCCCGTCGGCACCCGGACGCCCGCCGACGGGAAGAACGTCGCCGCGCTGGTGTGGCGGACGGGCCGTCCGGCGCGGGCCGACGAGAGCGGCGGCGCCGATCCGATCGCGGGCCCGCCCATGAACCCCCGGGGCTCGGCCGACCGCTCGGTGGCCGGCGTGCCGATCGAGGTCGGGGACCGGGTGTGGGGGGTCCTTCTGGTCTCCGCCGGGCGGTCGCTCCCGGCGTCCGCCGAGACACTACTCGCCGAGTTCGGCGAACTGGTCACGGTCTCCGTCTCGGCCGAGTTGAAGCAGGACCAACTGCTCTGCTTCGCCGACGATCAGGCGGCGCTGCGGCGCGTGGCGACCCTGGTCGCCACGGGGATGCCGCCGGAGGAGGTGTTCGCCGCCGTGGCCGCCGAGGTCGGGCAGTTGCTGGGCGCCGACGTGACGGGGATCAGCCGGTACGACCCGGACGGCACGGCGGCCGCCGTCGGCGGCTGGTCGGCGGCCGGCGGCGAGACGTCGTTCCCCGTCGGCACCCGGGTAACGCTGGGCGGGCGCAACGTGGTGACGCAGGTCTTCGAGACCGGCCGGCCGATGCGGATCGACCACGTCTCCCATGCCTCGGGGGCCCCGGCCGCCTTCGCCCGCGAGCGCGGGTTCGGTGCGATCGTCGGTGTGCCGATCTCCGTCGAGAACCGGATCTGGGGCGTCGTCATGGTGATCTCCATGCCGCCGCGCCCGCTGCCCCCGAGCACCGAGCAGCGGCTGGCCGACTTCACCCCACTCATCGCCACCGCCCTCGCCACCGCGCAGGCCCGCACGGAACTGCGCGCCTTCGCGGAGGAGCAGGCGGCGCTGCGGCGGGTGGCGACCCTGGTCGCCAAGGGGGCACCGCCCGAGGAGGTGTTCGCCGCCGTCACGGCGGAGGTCGGGCGGCTCTTCCACGTCGCTCTGACCGTCCTGACCCGCTACGACCCGGACGGCTCCGCCACGGTCCTCGGCAGTTGGAGCCGGGTCGGCATCCGGCGCTTCGCGGTCGGCAGGCGGCTGCGTCACCAGGACCGGACCTCGCACACGATCGTGCACCAGGCGGGCAGAGCGGCACGGATCGACGAGCCCGCCCCCGACTCCGACGGCGACTTCAGGACGATCGTCGGGGTGCCGATCCGGGTCGAGGGACGCCTGTGGGGGGTCATCAGCGTGGCCTGCTCCGAGAGGACGCTGCCGGGCGGCCTTGAGGACCAGCTTTCCGACTTCACCGAACTGATCGGCGCCGCCCTGGCCAACGCGGAGGCCAAGGCCGCGCTGACCGCGTCCAGGGCGCGGATCGTGGCCGCCGCCGACACCGCGCGCCGCCGGATCGAGCGCGACCTGCACGACGGCGCCCAGCAGCGCCTGGTCTCCCTGGCCCTGCAACTGCGCGCCGCCCAGATGGCGGTGCCGTCCGAGGTCCCAGGGCTCGACGAGGAACTGGACGAGGTGGCCGACGGGCTGGTCGCGGTGCTCGACGAACTGCGCGAGATCGCGCGGGGCATCCACCCGGCCGTGCTCGTCGAAGGCGGGCTCACCTCTGCGCTCAAGGCGCTGGCCCGCCGCTCCCCCGTGCCGGTCAGCCTGGACGTCAGGACCCGGGACCGTTTCCCGGAACCCGTCGAGATCGCCGCCTATTACGCCGTCTCCGAGGCGCTCACCAACGCCGCCAAGCACGCCCGCGCGAGCACCGTGGACGTGCACGTCACGGTCTCCGACGGGACATTGCGGATGACCATCGTCGACGACGGCCACGGCGGGGCCGACCCGGCACGCGGCTCCGGTCTCGTCGGGCTCGTCGACCGGGTCGAGGCCCTCGGCGGGCGGCTGTGGCTGGAGAGCCCGCCGGAGACCGGCACCACCGTACGGCTGGAGCTGCCGGTGTGA	MRFVGRWRGALLETETQTTAWTSDRIADEQGALRRVATLVAQGAATDEVFTTTTAEAGRLLGVDLAVLNRYEADGTMTVLGAWSGPDGLTPVPVGTRTPADGKNVAALVWRTGRPARADESGGADPIAGPPMNPRGSADRSVAGVPIEVGDRVWGVLLVSAGRSLPASAETLLAEFGELVTVSVSAELKQDQLLCFADDQAALRRVATLVATGMPPEEVFAAVAAEVGQLLGADVTGISRYDPDGTAAAVGGWSAAGGETSFPVGTRVTLGGRNVVTQVFETGRPMRIDHVSHASGAPAAFARERGFGAIVGVPISVENRIWGVVMVISMPPRPLPPSTEQRLADFTPLIATALATAQARTELRAFAEEQAALRRVATLVAKGAPPEEVFAAVTAEVGRLFHVALTVLTRYDPDGSATVLGSWSRVGIRRFAVGRRLRHQDRTSHTIVHQAGRAARIDEPAPDSDGDFRTIVGVPIRVEGRLWGVISVACSERTLPGGLEDQLSDFTELIGAALANAEAKAALTASRARIVAAADTARRRIERDLHDGAQQRLVSLALQLRAAQMAVPSEVPGLDEELDEVADGLVAVLDELREIARGIHPAVLVEGGLTSALKALARRSPVPVSLDVRTRDRFPEPVEIAAYYAVSEALTNAAKHARASTVDVHVTVSDGTLRMTIVDDGHGGADPARGSGLVGLVDRVEALGGRLWLESPPETGTTVRLELPV	MMGKISRAMLAVYSGIAAFLIILFSLFTYFYASNQSHWWGELLRARLLYVPLIFHLLAISLGVGLIVFLLLSLIQKTKYGKIEEKLRALSSGNYESKLLLLPIPSASDDLYIKDIDKEITKIKEKMIEVSSELQIVTSRPQYVDGQTKEEILELERHRLARELHDSVSQQLFAAMMMMSALTEQAEKSETPEMFRKQLKMVAEIINASQSEMRALLLHLRPVNLEEKSLKQGIEQLLKELQNKIQISLKWDVEDVKLSSSIEDHLFRIVQELLSNTLRHAKANELEVYLHKIDNNLLLRIIDDGTGFNMNETKTGSYGLNNIKERVAGIGGTVKIISFKGQGTSVEIKVPLMKEA	204.23	gnl|BL_ORD_ID|1948|hsp_num:0	1108			456	1053	daptomycin
BGC0000814.1|K-252a_16 # 21295 # 21675 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000814.1|K-252a_16 	21295	21675	-	Loose	400	38.5058	vanR gene in vanE cluster	29.89	3002924	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGTTTGGCCGCCGCGAGCGGTGGCAGCCTGAGGCTGTGGAGTTGCACTGCTTGATCGTCGACGACAGCCGGCGGTTTCTGCAGGCCGCGAGCCGGTTGCTGGAGCTGCAGGGCGCCCGGATCGTGGGCATGGCCACGACCGGGGCCGAGGCGGTGGCCCTGACCGAGGAACTGCGGCCCGACGTGGTCCTGGTCGACGTCGGGCTGCGCGAGGAGAGCGGCTTCGACGTGGCCGCCCTGCTGGACGGCGTCCCCGTCATCATGATCTCCACCCAGGACGGCGCCGACCTCGCCCAACTCGTCGAGGCGAGCCGGGCGATCGGCTTCCTGCCGAAGTCCGGGCTGTCCTGTGCGGCGATCCGCGACCTGCTCAGCACTTGA	MFGRRERWQPEAVELHCLIVDDSRRFLQAASRLLELQGARIVGMATTGAEAVALTEELRPDVVLVDVGLREESGFDVAALLDGVPVIMISTQDGADLAQLVEASRAIGFLPKSGLSCAAIRDLLST	MAKILILDDEKEIVSLLSTLLSNEGYEVYEAMSGKESLEIIENNKIDLAILDVMLPDISGFDVLQSIREKQFFPVLMLTARGQDMDKITGLSMGADDYIVKPFNPFEVLARVKTQLRRYQTYNSQSIDETNEYAKNGLNISVNSRKVFLYDEEIKLTPIEFDILWYLCRNEGRVISSEELFEKVWKEDYLENNNTVMAHIAKIREKMHEKPRQPNIIKTVWGVGYTIEK	55.02	gnl|BL_ORD_ID|4674|hsp_num:0	691			9	264	vancomycin
BGC0000814.1|K-252a_17 # 21681 # 23096 # -1 # ID=1_17;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.678	BGC0000814.1|K-252a_17 	21681	23096	-	Loose	500	26.1794	RSA-1	31.48	3004444	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	RSA beta-lactamase	GCCGGCTGCTTCACCACCTTCGGCCAGGCGTGGAACAACGGCGGGCCGGTCGCCATCTCCTGGGGCTGGCCGATCATCTCGGTCTTCATCCTGATCATCGGCCTGTGCATGGCCGAACTCGTCTCCGCCTATCCCACCGCCGGTGGCATCTACTGGTGGGCGGCGAAGATGGGCAGGCCCGTGCACGGCTGGTTCACCGGCTGGCTCAACCTCATCGGCCTCGTCGCCGTCACCGCCTCCGTCGACTACGGCGCGGCGACCTTCCTCAACATCACGCTCAACCGCTTCTTCGGGCTCCAGGTCTCCCTCGGCACCACGTTCACGATCTTCGTGGTGGTCCTGCTGCTGCACGCCCTGATCAACATCTTCAGCCACCGGCTGATCTCGGTGCTGCAGAACGTGTCGGTCTGGTGGCACGTGTTCGGCGCCGCGATCATCGTGGCCATCCTCGCCTTCGGCCCCGACAGCCACCAGTCGTTCGGCTTCGTCTTCACCGAGACGGTCAACAACTCCGGGTTCGCCGACTCCTCCTACTGGTTCTACGTGCTGCCGCTCGGCTTCCTGCTCACGCAGTACACGATCACCGGGTTCGACGCCTGCGCGCACGTCTCGGAGGAGACCAAGGGCGCCGCCACGGCCGCCGCCAGGGGGCTGTGGCAGTCGATCTTCTTCTCCGCGATCGGCGGGTGGATCCTGCTGCTGGCCTTCCTGTTCGCGGCGACGGACGTGGCGGCGGTCAACGAGGGCGGCGGATTCGTCGGGGCCATCTTCGACTCGGCGCTGCCGGGCAACCTGGCGACGGCGATCTTCGCGATCTCCGCGATCGGCCAGTTCTTCTGCGGGATGAGCTGCGTGACCTCGATGTCGCGGATGACCTACGCGTTCTCCCGCGACGGCGCCGTACCCGGCTGGCGGCTGTGGTCGCGCGTGGACCGCAACCGCACGCCGGTCAACGCCACCCTCGCCGGGTGCGCGGTCGCCGCCCTGCTGACCCTGCCCGCGCTCTACGCACCTCCCGGAACCACCACGCCGGTGGCCTTCTACGCCGTGGTGTCGATCGCGGTCATCGGGTTGTACCTGGCCTTCATCATCCCGATCTGGCTGCGGCTGCGCATGGGCGACCGGTTCGTCCCGGGGCCGTGGACGCTCGGGCGGAAGTACAAGGTCATGTGCTGGATCGCGGTGATCGAGATCGCCGTCGTCTGCGTCTACTTCGTGCTGCCGTTCGTGCCCGCCGGGGTGCCCGGCGACGCGGAGTTCACCTGGACGGCCGTCAACTACGCGCCGATCGCCGTCGGCGTGGTGCTGGTGGCGATCGGCCTGTGGTGGGTGCTGTCGGCTCGCAAGTGGTTCACGGGGCCGCGCCGTACGGTCGAGGAGAGCGTCGTGGAGCAGCCGTACGGATCTTCCAGCTAG	AGCFTTFGQAWNNGGPVAISWGWPIISVFILIIGLCMAELVSAYPTAGGIYWWAAKMGRPVHGWFTGWLNLIGLVAVTASVDYGAATFLNITLNRFFGLQVSLGTTFTIFVVVLLLHALINIFSHRLISVLQNVSVWWHVFGAAIIVAILAFGPDSHQSFGFVFTETVNNSGFADSSYWFYVLPLGFLLTQYTITGFDACAHVSEETKGAATAAARGLWQSIFFSAIGGWILLLAFLFAATDVAAVNEGGGFVGAIFDSALPGNLATAIFAISAIGQFFCGMSCVTSMSRMTYAFSRDGAVPGWRLWSRVDRNRTPVNATLAGCAVAALLTLPALYAPPGTTTPVAFYAVVSIAVIGLYLAFIIPIWLRLRMGDRFVPGPWTLGRKYKVMCWIAVIEIAVVCVYFVLPFVPAGVPGDAEFTWTAVNYAPIAVGVVLVAIGLWWVLSARKWFTGPRRTVEESVVEQPYGSSS	MGMQLARSTILTVLLCLPIAVTATTKEEIQKIERQRNLTVGIALVDDGGTLLFGHRETQRFAMCSTFKLPLAAATLKQIESGKWSAAERLSYSAGQLDAYAPAAKRYLPTGYITVAEANQASVQLSDNTAANLLLDKLGGPSQLTSMFRSLGDSVSRLDRREPDLNTNVSGDPRDTTTPGAMARIVAKLVYGNYLSTAGREQLQRLLIGNNTGDSRIRAGIASGWTTGDKTGSCPNGGRNDAAFLVSPDGRRFALTVYLNAPSLDDKARNEVVATVARLAVESIR	165.26	gnl|BL_ORD_ID|2493|hsp_num:0	2884			465	588	
